High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,559,495
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
Other
2026-03-12
$289,334
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
Other
|
2026-03-12 | $289,334 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
Other
2026-03-12
$386,225
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
Other
|
2026-03-12 | $386,225 | M | Form 4 |
|
DNTH
M
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
Other
2026-03-12
$217,700
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
Other
|
2026-03-12 | $217,700 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -36.3%
2026-03-12
$1,279,415Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -36.3%
|
2026-03-12 | $1,279,415Large | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -84.3%
2026-03-12
$1,918,264Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -84.3%
|
2026-03-12 | $1,918,264Large | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -88.5%
2026-03-12
$319,481
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -88.5%
|
2026-03-12 | $319,481 | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -40.0%
2026-03-12
$16,676
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 SellΔOwn -40.0%
|
2026-03-12 | $16,676 | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
CARR EDWARD
• Officer • CHIEF ACCOUNTING OFFICER
10b5-1 Sell
2026-03-12
$25,659
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
Officer • CHIEF ACCOUNTING OFFICER
10b5-1 Sell
|
2026-03-12 | $25,659 | S | Form 4 |